Gossamer Bio Inc GOSS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:40 PM EDT
0.70quote price arrow up+0.032 (+4.7904%)
Volume
1,284
Close
0.668quote price arrow down-0.002 (-0.2985%)
Volume
2,082,609
52 week range
0.45 - 1.88
Loading...
  • Open0.688
  • Day High0.71
  • Day Low0.6529
  • Prev Close0.67
  • 52 Week High1.88
  • 52 Week High Date07/20/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23

Key Stats

  • Market Cap150.689M
  • Shares Out225.58M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-26.79

KEY STATS

  • Open0.688
  • Day High0.71
  • Day Low0.6529
  • Prev Close0.67
  • 52 Week High1.88
  • 52 Week High Date07/20/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23
  • Market Cap150.689M
  • Shares Out225.58M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-26.79

RATIOS/PROFITABILITY

  • EPS (TTM)-1.38
  • P/E (TTM)-0.48
  • Fwd P/E (NTM)-0.88
  • EBITDA (TTM)-172.029M
  • ROE (TTM)-480.50%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)333.00%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gossamer Bio Inc

 

Profile

MORE
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH). Its product candidate Seralutinib, also known as GB002, is an investigational inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor, being evaluated in a Phase III clinical trial for the...
Faheem Hasnain
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Bryan Giraudo
Chief Financial Officer, Chief Operating Officer
Caryn Peterson
Executive Vice President - Regulatory Affairs
Christian Waage
Executive Vice President - Technical Operations and Administration
Address
3013 Science Park Rd
San Diego, CA
92121-1101
United States

Top Peers

SYMBOLLASTCHG%CHG
KOD
Kodiak Sciences Inc
3.28+0.09+2.98%
DRTS
Alpha Tau Medical Ltd
2.41+0.01+0.42%
ATOS
Atossa Therapeutics Inc
1.53+0.01+0.66%
ELEV
Elevation Oncology Inc
3.62-0.02-0.69%
INO
Inovio Pharmaceuticals Inc
10.57+0.45+4.40%